Ohio Judge Stays Design Defect Preemption Case Pending High Court’s Ruling in Bartlett

COLUMBUS, Ohio — Pending the U.S. Supreme Court’s ruling in Bartlett v. Mutual Pharmaceutical Co., a federal judge has stayed Sandoz Inc.’s challenge of his ruling that design defect and off-label promotion claims brought in connection with its generic antiarrhythmic drug are not federally preempted.

On April 22, Judge James L. Graham of the U.S. District Court for the Southern District of Florida held that the resolution of Bartlett may resolve the issue of whether those claims premised

Frederick Arters sued Sandoz and Eon Labs Inc. in the Delaware County (Ohio) Common Pleas Court, alleging he suffered eye damage …